CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 1, 2007, Pages 184-191

  Palmer, Brent E ^a   Mack, Douglas G ^a   Martin, Allison K ^a   Maier, Lisa A ^a,c   Fontenot, Andrew P ^a,b  

^a Departments of Medicine

^b UNIVERSITY OF COLORADO   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

beryllium; CD4 positive T lymphocytes; cytokines; granuloma; Human; lung

Indexed keywords

CD57 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2;

ANTIGEN EXPRESSION; ARTICLE; BERYLLIOSIS; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HUMAN; HUMAN CELL; LUNG ALVEOLITIS; LUNG LAVAGE; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL;

ALVEOLITIS, EXTRINSIC ALLERGIC; ANTIGENS, CD57; BERYLLIOSIS; BERYLLIUM; BRONCHOALVEOLAR LAVAGE; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; LUNG; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; TH1 CELLS;

EID: 34250805940     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.03.009     Document Type: Article

References (25)

1. Fontenot A.P., and Maier L.A. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease. Trends Immunol 26 (2005) 543-549
2. + T cells in patients with chronic beryllium disease. J Clin Invest 110 (2002) 1473-1482
3. Fontenot A.P., Gharavi L., Bennett S.R., Canavera S.J., Newman L.S., and Kotzin B.L. CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells. J Clin Invest 112 (2003) 776-784
4. Palmer B.E., Blyveis N., Fontenot A.P., and Wilson C.C. Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J Immunol 175 (2005) 8415-8423
5. Brenchley J.M., Karandikar N.J., Betts M.R., Ambrozak D.R., Hill B.J., Crotty L.E., et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101 (2003) 2711-2720
6. Kern F., Khatamzas E., Surel I., Frommel C., Reinke P., Waldrop S.L., et al. Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol 29 (1999) 2908-2915
7. Lieberman J., Trimble L.A., Friedman R.S., Lisziewicz J., Lori F., Shankar P., et al. Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection. AIDS 13 (1999) 891-899
8. Papagno L., Spina C.A., Marchant A., Salio M., Rufer N., Little S., et al. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2 (2004) E20
9. Imberti L., Sottini A., Signorini S., Gorla R., and Primi D. Oligoclonal CD4+ CD57+ T-cell expansions contribute to the imbalanced T-cell receptor repertoire of rheumatoid arthritis patients. Blood 89 (1997) 2822-2832
10. Jimenez-Martinez M.C., Linares M., Baez R., Montano L.F., Martinez-Cairo S., Gorocica P., et al. Intracellular expression of interleukin-4 and interferon-gamma by a Mycobacterium tuberculosis antigen-stimulated CD4+ CD57+ T-cell subpopulation with memory phenotype in tuberculosis patients. Immunology 111 (2004) 100-106
11. Legac E., Autran B., Merle-Beral H., Katlama C., and Debre P. CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood 79 (1992) 1746-1753
12. Maeda T., Yamada H., Nagamine R., Shuto T., Nakashima Y., Hirata G., et al. Involvement of CD4+, CD57+ T cells in the disease activity of rheumatoid arthritis. Arthritis Rheum 46 (2002) 379-384
13. Wahlström J., Berlin M., Skold C.M., Wigzell H., Eklund A., and Grunewald J. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 54 (1999) 339-346
14. + T cells in blood determines proliferative response. J Clin Invest 115 (2005) 2886-2893
15. Newman L.S., Kreiss K., King Jr. T.E., Seay S., and Campbell P.A. Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history. Am Rev Respir Dis 139 (1989) 1479-1486
16. Rossman M.D., Kern J.A., Elias J.A., Cullen M.R., Epstein P.E., Preuss O.P., et al. Proliferative response of bronchoalveolar lymphocytes to beryllium. Ann Intern Med 108 (1988) 687-693
17. Newman L.S. Significance of the blood beryllium lymphocyte proliferation test. Environ Health Perspect 104 (1996) 953S-956S
18. Mroz M.M., Kreiss K., Lezotte D.C., Campbell P.A., and Newman L.S. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol 88 (1991) 54-60
19. Tinkle S.S., Kittle L.A., Schumacher B.A., and Newman L.S. Beryllium induces IL-2 and IFN-γ in berylliosis. J Immunol 158 (1997) 518-526
20. Sallusto F., Lenig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712
21. Watanabe H., Weerasinghe A., Miyaji C., Sekikawa H., Toyabe S., Mannor M.K., et al. Expansion of unconventional T cells with natural killer markers in malaria patients. Parasitol Int 52 (2003) 61-70
22. Jones-Williams W., and Kelland D. New aid for diagnosing chronic beryllium disease (CBD): laser ion mass analysis (LIMA). J Clin Pathol 39 (1986) 900-901
23. Sawyer R.T., Abraham J.L., Daniloff E., and Newman L.S. Secondary ion mass spectroscopy demonstrates retention of beryllium in chronic beryllium disease granulomas. J Occup Environ Med 47 (2005) 1218-1226
24. Palmer B.E., Boritz E., and Wilson C.C. Effects of sustained HIV-1 plasma viremia on HIV-1 gag-specific CD4+ T cell maturation and function. J Immunol 172 (2004) 3337-3347
25. + T cell proliferation. Proc Natl Acad Sci U S A 98 (2001) 13878-13883